| Financial Year |
March 31 2023 |
| Monetary Funds |
3,257,507,176.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,075,560,701.69 |
| Accounts Receivable |
1,343,283,749.42 |
| Advances to Suppliers |
222,985,322.76 |
| Other Receivables |
13,655,920.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,206,663,444.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
200,856,406.19 |
| Total Current Assets |
7,958,284,897.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
25,500,000.00 |
| Investment Properties |
1,101,375.84 |
| Fixed Assetes |
5,268,230,756.47 |
| Under-construction Projects |
705,364,072.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
425,486,315.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
95,567,758.71 |
| Deferred Income Tax Assets |
157,872,828.49 |
| Other Non-Current Assets |
770,388,323.23 |
| Sub-Total of Non-Current Assets |
8,013,170,941.85 |
| Total Assets |
15,971,455,839.24 |
| Short-Term Loans |
1,315,174,616.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,185,002,334.70 |
| Accounts Payable |
1,409,183,543.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
119,663,271.17 |
| Taxes Payable |
113,262,020.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
114,982,154.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
377,289,860.00 |
| Other Current Liabilities |
135,015,712.19 |
| Sub-Total of Current Liabilities |
6,080,238,215.17 |
| Long-term Loans |
1,645,798,294.21 |
| Bonds Payable |
1,624,069,478.99 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
26,017,084.52 |
| Deferred Income Tax Liabilities |
49,597,462.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,446,902,785.60 |
| Total Liabilities |
9,527,141,000.77 |
| Paid-In Capital(Or Share Stock) |
1,147,213,124.00 |
| Capital Surplus |
2,479,071,207.86 |
| Surplus Reserve |
391,169,748.90 |
| LESS:Treasury Stock |
82,279,758.04 |
| Undistributed Profits |
2,217,860,707.94 |
| Minority Stockholder's Interest |
43,047,178.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,401,267,659.83 |
| Owner's Equity（Stockholder's Equity） |
6,444,314,838.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,971,455,839.24 |
